Lupin And Mark Cuban Shake Hands On Spiriva Alliance In US

Indian Firm Recently Launched First Generic; Aiming For 40%+ Share

 
• By Dean Rudge
  
Mark Cuban headshot
Lupin has struck a deal with the Mark Cuban Cost Plus Drug Company • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business